Kliniske studier for Trøtthet i California
6 studier for Trøtthet søker deltakere på steder i California.
Byer i California
Offisiell studietekst (engelsk)
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
- UC San Diego Medical Center - Encinitas, Encinitas
- Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
- UCI Health - Irvine, Irvine
- og 14 flere
RekruttererFase 2/3
Alder 18 og eldre · Alle kjønn · Oppdatert 25. sep. 2026 · NCT06989437A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Idiopathic Hypersomnia (IH)
- Stanford Center for Sleep Medicine, Redwood City
- Trial Site Solutions, San Ramon
- Santa Monica Clinical Trials, Santa Monica
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 14. sep. 2026 · NCT07500090A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1
- Alkermes Investigational Site, Los Angeles
RekruttererFase 3
Alder 18 til 70 · Alle kjønn · Oppdatert 3. sep. 2026 · NCT07455383A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Narcolepsy
- West Coast Pulmonary & Sleep Disorders Center, Lancaster
- Santa Monica Clinical Trials, Los Angeles
- Stanford Center for Sleep Sciences and Medicine, Redwood City
- og 2 flere
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 27. aug. 2026 · NCT07675135Biofield Therapy for the Support of Immunotherapy-related Symptoms Among Adult Cancer Patients - A Pilot Study
- UCI Health Susan Samueli Integrative Health Institute, Irvine
- UCI Health, Orange
Rekrutterer
Alder 18 og eldre · Alle kjønn · Oppdatert 10. jul. 2026 · NCT07581080Sodium Bicarbonate and Mitochondrial Energetics in Persons With CKD
- University of California Davis Health, Sacramento
RekruttererFase 2
Alder 21 til 85 · Alle kjønn · Oppdatert 6. mai 2026 · NCT04984226Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.